Fully automatic co-registration of functional to anatomical brain images us
ing information intrinsic to the scans has been validated in a clinical set
ting for positron emission tomography (PET), but not for single-photon emis
sion tomography (SPET). In this paper we evaluate technetium-99m hexamethyl
propylene amine oxime to magnetic resonance (MR) co-registration for five f
ully automatic methods. We attached six small fiducial markers, visible in
both SPET and MR: to the skin of 13 subjects. No increase in the radius of
SPET acquisition was necessary. Distortion of the fiducial marker distribut
ion observed in the SPET acid MR studies was characterised by a measure ind
ependent of registration and three subjects were excluded on the basis of e
xcessive distortion. The location of each fiducial marker was determined in
each modality to sub-pixel precision and the inter-modality distance was a
veraged over all markers to give a fiducial registration error (FRE). The c
omponent of FRE excluding the variability inherent in the validation method
was estimated by computing the error transformation between the arrays of
MR marker locations and registered SPET marker locations. When applied to t
he fiducial marker locations this yielded the surface registration error (S
RE), and when applied to a representative set of locations within the brain
it yielded the intrinsic registration error (IRE). For the best method, me
an IRE was 1.2 mm, SRE 1.5 mm and FRE 2.4 mm (with corresponding maxima of
3.3, 4.3 and 5.0 mm). All methods yielded a mean IRE <3 mm. The accuracy of
the most accurate fully automatic SPET to MR co-registration was comparabl
e with that published for PET to MR. With high standards of calibration and
instrumentation, intra-subject cerebral SPET to MR registration accuracy o
f <2 mm is attainable.